DAX22.563 +1,2%Est505.542 +0,7%MSCI World4.343 -0,1%Top 10 Crypto8,6700 +1,2%Nas20.795 -0,7%Bitcoin58.720 +0,9%Euro1,1471 ±0,0%Öl113,5 -0,8%Gold4.559 +1,1%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 SAP 716460 Siemens Energy ENER6Y NVIDIA 918422 BASF BASF11 Lufthansa 823212 Microsoft 870747 Deutsche Telekom 555750 DroneShield A2DMAA BYD A0M4W9 Allianz 840400 RENK RENK73 Novo Nordisk A3EU6F Volkswagen (VW) vz. 766403 Vonovia A1ML7J
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX stabil erwartet -- Asiens Börsen schwächer -- Rheinmetall: Selenskyj widerspricht CEO Papperger nach Drohnen-Debatte -- Siemens Energy im Fokus
Top News
ProSiebenSat.1--Aktie: Analyst senkt Kursziel deutlich wegen hoher Schulden ProSiebenSat.1--Aktie: Analyst senkt Kursziel deutlich wegen hoher Schulden
Unilever-Aktie: Milliardenfusion mit McCormick nimmt Gestalt an Unilever-Aktie: Milliardenfusion mit McCormick nimmt Gestalt an
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

AstraZeneca Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
167,00 EUR -1,90 EUR -1,12 %
STU
168,75 EUR -0,40 EUR -0,24 %
HAML
finanzen.net zero
AstraZeneca jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.255,03 Mrd. EUR

KGV27,55Div. Rendite1,71%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN886455

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINGB0009895292

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolAZN

AstraZeneca Aktien News

DatumMeistgelesen
PR NewswireTurbine Launches Collaboration with AstraZeneca, Leveraging Turbine's Virtual Disease Models to Rationalize ADC Discovery
PR NewswireSOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer
PR NewswireSOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer
Wer­bungAstraZeneca-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireSOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer
PR NewswireSOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer
PR NewswireThe Healthcare Businesswomen's Association (HBA) Honors AstraZeneca and Viseven with 2025 ACE Awards for Workforce Innovation and Global Impact
PR NewswireAlexion, AstraZeneca Rare Disease reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for Ultomiris for the treatment of adults with neuromyelitis optica spectrum disorder (N...
PR NewswireAlexion, AstraZeneca Rare Disease reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for Ultomiris for the treatment of adults with neuromyelitis optica spectrum disorder (N...
PR NewswireSOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes
PR NewswireSOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes
PR NewswireSOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes
PR NewswireSOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes
PR NewswireDanaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine
PR NewswireSOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
PR NewswireSOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
PR NewswireSOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
PR NewswireSOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
PR NewswireIgniteData launches cutting edge data integration platform for clinical trials at Cambridge University Hospitals
PR NewswireLeading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing
PR NewswireFinal Deadline for the AstraZeneca PLC Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - AZN
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZN
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZN
PR NewswireAstraZeneca PLC Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before February 21, 2025 to Discuss Your Rights - AZN
PR NewswireShareholders that lost money on AstraZeneca PLC(AZN) Urged to Join Class Action - Contact The Gross Law Firm to Learn More
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZN
PR NewswireAstraZeneca plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery
PR NewswireAstraZeneca plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZN
PR NewswireAstraZeneca PLC (AZN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
PR NewswireThe Gross Law Firm Notifies AstraZeneca PLC Investors of a Class Action Lawsuit and Upcoming Deadline - AZN
PR NewswireSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZN
PR NewswireASTRAZENECA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Ag...
PR NewswireAZN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AstraZeneca PLC. of Class Action Lawsuit and Upcoming Deadlines - AZN
PR NewswireAZN Investors have Opportunity to Lead AstraZeneca PLC Securities Fraud lawsuit
PR NewswireRosen Law Firm Encourages AstraZeneca PLC Investors to Inquire About Securities Class Action Investigation - AZN
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC - AZN
PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC - AZN
PR NewswireGRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study

AstraZeneca News

AstraZeneca News: auf dieser Seite finden Sie alle AstraZeneca News und Nachrichten zur AstraZeneca Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch AstraZeneca News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um AstraZeneca News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.